Nearly 90% of patients treated with Biotron's (ASX:BIT) Hepatitis C treatment candidate demonstrated a complete EVR at three month follow-up. [ + ]

Australian biotechs will have access to a slice of $200m in startup funding, from VC firms applying for the latest tranche of the government's Innovation Investment Fund. [ + ]

The National Imaging Facility (NIF) Research Cyclotron was officially opened today, bringing the radioisotope production, radiolabelling and biomedical imagery to life science researchers. [ + ]

Australian Research Council CEO Professor Margaret Sheil will leave the ARC in April 2012 to take up position as University of Melbourne Provost. [ + ]

AusBiotech will host two consultation policy fora in its Policy Summit of industry thought leaders this week to determine public policy direction in regard to biotechnology and medical technology for the coming one to three years. [ + ]

Several leading life scientists have landed Australian Academy of Science awards for scientific excellence. [ + ]

Tissue treated with Allied Healthcare Group's ADAPT tissue engineering technology showed significantly reduced calcification in preclinical trials. [ + ]

Cancer treatment development company Patrys (ASX:PAB) has raised $3.4m in an oversubscribed placement to fund clinical trials for its antibody-based products. [ + ]

CBio appoints new chairman, interim MD; AusBiotech CEO joins Research Australia board; Timothy Waugh named Hatchtech CEO.

The National Health and Medical Research Council has issued its annual slew of Excellent Awards for 2011-2012, handing out accolades to some of the nation's top life scientists. [ + ]

Groundbreaking protein and cell biology research has discovered a new way to alter the survival of cancer cells by targeting active sarcoma kinase signalling.

The Australian Academy of Science urged the Federal Government to increase its efforts to attract and retain university students in science and mathematics.

Sydney researchers have discovered a new population of adult stem cells in the heart which could augment the development of new regeneration and repair therapies for people who have suffered heart attack or heart failure - the leading cause of death in Australia.

AusBiotech will be lobbying for a greater emphasis on biopharma and medical devices on the newly established Prime Minister's Taskforce on Manufacturing. [ + ]

Biotechnology Advisory Council will advise the government on current and emerging opportunities and threats to the biotechnology sector and aid in implementation of policy. [ + ]